JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dyer, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dyer, D. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 188, Issue 2, 336-341, 1974
Copyright © 1974 by American Society for Pharmacology and Experimental Therapeutics


EVIDENCE FOR THE ACTION OF d-LYSERGIC ACID DIETHYLAMIDE, MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS IN UMBILICAL VASCULATURE

Donald C. Dyer 1

1 Department of Pharmacology and The Anesthesia Research Center, School of Medicine, University of Washington, Seattle, Washington

The contractions produced to 5-hydroxytryptamine, d-lysergic acid diethylamide (LSD), mescaline and bufotenine were studied on isolated helically cut sheep umbilical arteries. Phenoxybenzamine antagonized contractions to all four of the above agonists. When the tissues were incubated with 5-hydroxytryptamine (1.7 x 10-4 M) before and during exposure to phenoxybenzamine, the degree of block of the contractions to 5-hydroxytryptamine produced by phenoxybenzamine was less, i.e., the 5-hydroxytryptamine protected its own receptors against attack by the phenoxybenzamine. However, neither histamine, acetylcholine, norepinephrine nor angiotensin protected 5-hydroxytryptamine receptors. 5-Hydroxytryptamine did not protect norepinephrine or acetyhchohine receptors. 5-Hydroxytryptamine protected receptors mediating contractions for mescaline, bufotenine and LSD against block by the phenoxybenzamine. Also, mescaline and bufotenine protected 5-hydroxytryptamine receptors. Cross-protection experiments between LSD and 5-hydroxytryptamine could not be studied because of the prolonged time needed for the tissue to return to base line, even with repeated washes, when exposed to LSD. Mescaline protected receptors mediating contractions for LSD. The present study is in agreement with our previous experiments (Dyer, D.C. and Gant, D.W.: J. Pharmacol. Exp. Ther. 184: 366-375, 1973) in which LSD, mescaline and bufotenine were found to contract umbilical vasculature via 5-hydroxytryptamine receptors.

Submitted on February 21, 1973
Accepted on October 2, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics.